IN2014KO01267A - - Google Patents

Info

Publication number
IN2014KO01267A
IN2014KO01267A IN1267KO2014A IN2014KO01267A IN 2014KO01267 A IN2014KO01267 A IN 2014KO01267A IN 1267KO2014 A IN1267KO2014 A IN 1267KO2014A IN 2014KO01267 A IN2014KO01267 A IN 2014KO01267A
Authority
IN
India
Prior art keywords
bilirubin
decomposition
mn3o4
compositions
therapeutic agent
Prior art date
Application number
Other languages
English (en)
Inventor
Anupam; Giri
Nirmal; Goswami
Chandan; Sasmal
Nabarun; Polley
Dipanwita; Majumdar
Sounik; Sarkar
Sambhu Nath; Bandyopadhyay
Achintya; Singha
Samir Kumar; Pal
Original Assignee
S N Bose Nat Ct For Basic Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S N Bose Nat Ct For Basic Sciences filed Critical S N Bose Nat Ct For Basic Sciences
Priority to IN1267KO2014 priority Critical patent/IN2014KO01267A/en
Publication of IN2014KO01267A publication Critical patent/IN2014KO01267A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1267KO2014 2014-12-04 2014-12-04 IN2014KO01267A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1267KO2014 IN2014KO01267A (ko) 2014-12-04 2014-12-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1267KO2014 IN2014KO01267A (ko) 2014-12-04 2014-12-04

Publications (1)

Publication Number Publication Date
IN2014KO01267A true IN2014KO01267A (ko) 2015-05-15

Family

ID=54395678

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1267KO2014 IN2014KO01267A (ko) 2014-12-04 2014-12-04

Country Status (1)

Country Link
IN (1) IN2014KO01267A (ko)

Similar Documents

Publication Publication Date Title
CY1120506T1 (el) Θεραπευτικα δραστικες ενωσεις και μεθοδοι χρησης αυτων
MX2015010079A (es) Compuestos de tubulisina, metodos para obtenerlos y uso.
PH12017500070A1 (en) Methods of treating cancer using tigit inhibitors and anti-cancer agents
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX2018014175A (es) Conjugados de anticuerpo-fármaco anti-cmet y métodos para su uso.
EA201891607A1 (ru) Axl-специфичные конъюгаты антитело-лекарственное средство для лечения злокачественных новообразований
MX2018004832A (es) Selectividad de mutante y combinaciones de un compuesto inhibidor de fosfoinositida 3 cinasa y agentes quimioterapeuticos para el tratamiento de cancer.
MX2017016492A (es) Metodos para tratar tumores solidos usando terapia de combinacion de nanoparticula del inhibidor del objetivo mamifero de la rapamicina (mtor).
MX2017004471A (es) Compuestos de triazolopiridina y métodos para el tratamiento de fibrosis cística.
PH12015500940A1 (en) Bruton`s tyrosine kinase inhibitors
WO2015009726A3 (en) Medical uses of cd38 agonists
TWD161529S (zh) 治療燈
MX2016005532A (es) Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades.
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
MX2015011783A (es) Metodos para tratar tumores solidos pediatricos.
PH12016502352A1 (en) Pharmaceutical composition
MX2017015896A (es) Agente anticancerigeno.
TW201613578A (en) Pharmaceutical combinations
AU2015267099A8 (en) Use of eribulin in the treatment of cancer
MX2017002489A (es) Agentes terapeuticos humanos.
MX2020001727A (es) Terapia de combinacion.
MX2019013862A (es) Terapia de combinacion.
JOP20190056B1 (ar) مركبات للاستخدام في علاج القصور الكلوي الحاد
TW201713323A (en) Therapeutic compositions and methods of use thereof
MX2022014792A (es) Cocristales, composiciones farmaceuticas de los mismos y metodos de tratamiento que los implican.